Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Carbon Dioxide for Episodic Cluster Headache
NCT02381795Phase 2Terminated
- Start
- Jul 2015
- Primary completion
- Apr 2017
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Carbon dioxide in Cluster Headache (CH). Primary endpoint: Headache Pain Intensity. Started Jul 2015; status: terminated.
02
Drugs
Carbon dioxide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT02381795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02381795.